155 related articles for article (PubMed ID: 24696220)
1. Delta-like ligand 4 (DLL4) in the plasma and neoplastic tissues from breast cancer patients: correlation with metastasis.
Kontomanolis E; Panteliadou M; Giatromanolaki A; Pouliliou S; Efremidou E; Limberis V; Galazios G; Sivridis E; Koukourakis MI
Med Oncol; 2014 May; 31(5):945. PubMed ID: 24696220
[TBL] [Abstract][Full Text] [Related]
2. High DLL4 expression in tumour-associated vessels predicts for favorable radiotherapy outcome in locally advanced squamous cell head-neck cancer (HNSCC).
Koukourakis MI; Giatromanolaki A; Sivridis E; Gatter KC; Harris AL
Angiogenesis; 2013 Apr; 16(2):343-51. PubMed ID: 23108591
[TBL] [Abstract][Full Text] [Related]
3. Expression of Delta Like Ligand 4 (DLL4) in endometrial carcinomas and tumor vasculature.
Fasoulakis Z; Galazios G; Koukourakis M; Nikolettos N; Giatromanolaki A; Koutlaki N; N Kontomanolis E
J BUON; 2021; 26(4):1327-1332. PubMed ID: 34564988
[TBL] [Abstract][Full Text] [Related]
4. Anti-Cancer Effect of Melatonin via Downregulation of Delta-like Ligand 4 in Estrogen-Responsive Breast Cancer Cells.
Rajabi A; Saber A; Pourmahdi M; Emami A; Ravanbakhsh R; Khodavirdipour A; Khodaei M; Akbarzadeh M; Abdolahi S; Hosseinpourfeizi MA; Safaralizadeh R
Recent Pat Anticancer Drug Discov; 2020; 15(4):329-340. PubMed ID: 32990541
[TBL] [Abstract][Full Text] [Related]
5. Expression of vascular notch ligand delta-like 4 and inflammatory markers in breast cancer.
Jubb AM; Soilleux EJ; Turley H; Steers G; Parker A; Low I; Blades J; Li JL; Allen P; Leek R; Noguera-Troise I; Gatter KC; Thurston G; Harris AL
Am J Pathol; 2010 Apr; 176(4):2019-28. PubMed ID: 20167860
[TBL] [Abstract][Full Text] [Related]
6. Endothelial Delta-like 4 (DLL4) promotes renal cell carcinoma hematogenous metastasis.
Huang QB; Ma X; Li HZ; Ai Q; Liu SW; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Zhang X
Oncotarget; 2014 May; 5(10):3066-75. PubMed ID: 24931473
[TBL] [Abstract][Full Text] [Related]
7. DLL4 overexpression increases gastric cancer stem/progenitor cell self-renewal ability and correlates with poor clinical outcome via Notch-1 signaling pathway activation.
Miao ZF; Xu H; Xu HM; Wang ZN; Zhao TT; Song YX; Xu YY
Cancer Med; 2017 Jan; 6(1):245-257. PubMed ID: 27891816
[TBL] [Abstract][Full Text] [Related]
8. Highly Expressed DLL4 and JAG1: Their Role in Incidence of Breast Cancer Metastasis.
Zohny SF; Zamzami MA; Al-Malki AL; Trabulsi NH
Arch Med Res; 2020 Feb; 51(2):145-152. PubMed ID: 32111499
[TBL] [Abstract][Full Text] [Related]
9. Aberrant expression and association of VEGF and Dll4/Notch pathway molecules under hypoxia in patients with lung cancer.
Yu S; Sun J; Zhang J; Xu X; Li H; Shan B; Tian T; Wang H; Ma D; Ji C
Histol Histopathol; 2013 Feb; 28(2):277-84. PubMed ID: 23275310
[TBL] [Abstract][Full Text] [Related]
10. Down-Regulated miR-30a in Clear Cell Renal Cell Carcinoma Correlated with Tumor Hematogenous Metastasis by Targeting Angiogenesis-Specific DLL4.
Huang QB; Ma X; Zhang X; Liu SW; Ai Q; Shi TP; Zhang Y; Gao Y; Fan Y; Ni D; Wang BJ; Li HZ; Zheng T
PLoS One; 2013; 8(6):e67294. PubMed ID: 23826258
[TBL] [Abstract][Full Text] [Related]
11. Elevated DLL4 expression is correlated with VEGF and predicts poor prognosis of nasopharyngeal carcinoma.
Zhang JX; Cai MB; Wang XP; Duan LP; Shao Q; Tong ZT; Liao DZ; Li YY; Huang MY; Zeng YX; Shao JY
Med Oncol; 2013 Mar; 30(1):390. PubMed ID: 23275120
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of δ-like ligand 4 contributes significantly to axillary lymph node metastasis and predicts postoperative outcome in breast cancer.
Xiao M; Yang S; Ning X; Huang Y
Hum Pathol; 2014 Nov; 45(11):2302-10. PubMed ID: 25260720
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological significance of altered Notch signaling in extrahepatic cholangiocarcinoma and gallbladder carcinoma.
Yoon HA; Noh MH; Kim BG; Han JS; Jang JS; Choi SR; Jeong JS; Chun JH
World J Gastroenterol; 2011 Sep; 17(35):4023-30. PubMed ID: 22046092
[TBL] [Abstract][Full Text] [Related]
14. High delta-like ligand 4 (DLL4) is correlated with peritumoral brain edema and predicts poor prognosis in primary glioblastoma.
Qiu XX; Chen L; Wang CH; Lin ZX; Zhou CF; Liu SY; Wang XF; Chen YP
Medicine (Baltimore); 2014 Aug; 93(8):e57. PubMed ID: 25121357
[TBL] [Abstract][Full Text] [Related]
15. Influence of up-regulation of Notch ligand DLL4 on biological behaviors of human gastric cancer cells.
Li GG; Li L; Li C; Ye LY; Li XW; Liu DR; Bao Q; Zheng YX; Xiang DP; Chen L; Chen J
World J Gastroenterol; 2013 Jul; 19(28):4486-94. PubMed ID: 23901223
[TBL] [Abstract][Full Text] [Related]
16. Clinical implications of DLL4 expression in gastric cancer.
Ishigami S; Arigami T; Uenosono Y; Okumura H; Kurahara H; Uchikado Y; Setoyama T; Kita Y; Kijima Y; Nishizono Y; Nakajo A; Owaki T; Ueno S; Natsugoe S
J Exp Clin Cancer Res; 2013 Jul; 32(1):46. PubMed ID: 23898884
[TBL] [Abstract][Full Text] [Related]
17. Expression of delta-like ligand 4 (Dll4) and markers of hypoxia in colon cancer.
Jubb AM; Turley H; Moeller HC; Steers G; Han C; Li JL; Leek R; Tan EY; Singh B; Mortensen NJ; Noguera-Troise I; Pezzella F; Gatter KC; Thurston G; Fox SB; Harris AL
Br J Cancer; 2009 Nov; 101(10):1749-57. PubMed ID: 19844231
[TBL] [Abstract][Full Text] [Related]
18. Synergistic antitumor activity of a DLL4/VEGF bispecific therapeutic antibody in combination with irinotecan in gastric cancer.
Kim DH; Lee S; Kang HG; Park HW; Lee HW; Kim D; Yoem DH; Ahn JH; Ha E; You WK; Lee SH; Kim SJ; Chun KH
BMB Rep; 2020 Nov; 53(10):533-538. PubMed ID: 32580836
[TBL] [Abstract][Full Text] [Related]
19. The Vascular Notch Ligands Delta-Like Ligand 4 (DLL4) and Jagged1 (JAG1) Have Opposing Correlations with Microvascularization but a Uniform Prognostic Effect in Primary Glioblastoma: A Preliminary Study.
Qiu XX; Chen L; Wang CH; Lin ZX; Chen BJ; You N; Chen Y; Wang XF
World Neurosurg; 2016 Apr; 88():447-458. PubMed ID: 26546995
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of the Notch ligand Delta-like 4 inhibits VEGF-induced endothelial cell function.
Williams CK; Li JL; Murga M; Harris AL; Tosato G
Blood; 2006 Feb; 107(3):931-9. PubMed ID: 16219802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]